XML 15 R5.htm IDEA: XBRL DOCUMENT v3.20.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Cash flows from operating activities:    
Net loss $ (2,981,947) $ (6,541,626)
Adjustments to reconcile net loss to net cash provided by operating activities:    
Depreciation and amortization 792,104 835,302
Amortization of deferred gain on sale/leaseback (45,700) (82,422)
Gain on forgiveness of PPP Funding (1,047,700)
Provision for losses on accounts receivable 20,666 399,463
Provision for losses on inventories (40,482) 1,249,519
Other 248,974
Impairment on assets held for sale 604,483
Gain on deconsolidation of Clever (218,534)
Impairment of Related Party Note Receivable 350,000
Impairment of Prepaid, Current and Non Current Assets 168,931
Impairment of long-lived assets 1,252,283
Stock Based Compensation 72,401
Loss on disposition of Asset 17,480
Change in assets and liabilities:    
Accounts receivable 2,915,506 2,776,396
Inventories 2,314,744 1,435,411
Prepaid expenses and other assets (289,820) 228,389
Operating Lease Liability (470,771)
Trade payables (852,231) 1,892,670
Accrued liabilities 330,695 (166,823)
Net cash provided by operating activities 995,064 4,172,297
Cash flows from investing activities:    
Purchases of property, plant and equipment (139,708) (144,222)
Net cash used in investing activities (139,708) (144,222)
Cash flows from financing activities:    
Change in checks written in excess of bank balance 29,837 (391,313)
Repayment of debt and revolving line of credit (10,158,387) (4,721,867)
Proceeds from Issuance of Convertible Preferred Stock 1,500,000
Proceeds from issuance of stock 5,426,601
Cash paid for stock issuance costs (1,024,313)
Amortization of deferred financing fees 64,887 (82,763)
Proceeds from PPP 1,047,700
Proceeds from issuance of long-term debt 876,791 650,000
Net cash used in financing activities (2,236,884) (4,545,943)
Effect of exchange rate changes on cash 536,430 205,692
Net decrease in cash and cash equivalents (845,098) (312,176)
Cash and cash equivalents at beginning of period 845,098 428,150
Cash and cash equivalents at end of period [1] 115,974
Supplemental disclosure of cash flow information:    
Cash payments for interest 1,033,350 1,558,817
Common stock issued 306,000
Conversion of debt to Series A Preferred 478,000
Accrued Dividend on preferred stock 255,000
Issuance of Placement agent warrants in connection with Series A Preferred offering 919,000
Amortization of beneficial conversion feature and deemed dividend on Series A Preferred stock 2,200,000
Conversion from Accounts Payable To Common Stock [Member]    
Supplemental disclosure of cash flow information:    
Common stock issued 303,000
Conversion from Notes Payable To Common Stock [Member]    
Supplemental disclosure of cash flow information:    
Common stock issued $ 600,000
[1] The cash flows related to discontinued operations have not been segregated, and are included in the Consolidated Statements of Cash Flows. The cash and equivalents amounts presented above differ from cash and equivalents in the Consolidated Balance Sheets due to cash included in "Current assets of discontinued operations of $170,000."